- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02845427
Closed Suction Drain or Not After Total Hip Arthroplasty
Closed Suction Drain or Not After Total Hip Arthroplasty: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Total Hip Arthroplasty (THA) wounds are prone to formation of hematomas. Hematomas may increase the incision tension, leading to wound discharge and providing a good medium for bacteria, increase post-operative pain, limitation of range of motion of hip joint and prolong post-operative rehabilitation duration, also may cause ecchymosis, and tension vesicles around the surgical wound.
So use of closed suction drain system may reduce these complications. Nevertheless some recent studies have claimed that drainage can cause other complications and does not reduce hematoma formation and risk for infection. Furthermore, some studies have shown that drainage increase blood loss after THA which may both lead to increase blood transfusion requirements and provide an entry point for skin microorganisms.
Some other studies have found that no significance between use and non use of suction drain after THA.
So the investigators will take this issue for study a comparison between benefits and hazards of use and non use of suction drain after THA.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 71111
- Faculty of medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary total hip arthroplasty (THA)
Exclusion Criteria:
- Revision cases
- Uncontrolled bleeding tendency (prothrombin conc. Less than 70%)
- History of deep venous thrombosis
- Sever liver impairment (liver failure)
- Sever renal impairment (S. creatinine more than 3)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: A(drain group)
patients of primary THA will have closed suction drain introduced intraoperative at surgical site
|
using closed suction drain system postoperative
|
|
Placebo Comparator: B(No drain group)
patients of primary THA will have the surgical wound be closed with no suction drain
|
the surgical wound will be closed with no suction drain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in Hb level
Time Frame: preoperative and 24 hrs postoperative
|
preoperative and 24 hrs postoperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
amount of blood loss
Time Frame: upto 24 hrs postoperative
|
upto 24 hrs postoperative
|
|
amount of blood transfusion
Time Frame: upto 24 hrs postoperative
|
upto 24 hrs postoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AUHOR1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
National Taiwan University HospitalUnknownTotal Hip Replacement | Total Hip ArthroplastyTaiwan
-
Ortho Development CorporationOregon Health and Science UniversityEnrolling by invitationTotal Hip Replacement | Total Hip ArthroplastyUnited States
-
The Affiliated Hospital Of Southwest Medical UniversityCompletedTotal Knee Arthroplasty | Total Hip Arthroplasty | ERASChina
-
Bispebjerg HospitalNot yet recruitingTotal Hip Arthroplasty (THA) | Revision Hip Arthroplasty
-
James A. KeeneyCompletedPrimary Total Hip Arthroplasty | Primary Total Knee ArthroplastyUnited States
-
Rush University Medical CenterRecruitingAnterior Cruciate Ligament Reconstruction | Total Knee Arthroplasty | Hip Arthroscopy | Total Hip Arthroplasty (THA)United States
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
Clinical Trials on closed suction drain
-
University Hospital Hradec KraloveCompletedPancreaticoduodenectomy | Distal PancreatectomyCzech Republic
-
Shifa International HospitalCompletedKnee Osteoarthritis | Total Knee ArthroplastyPakistan
-
University of RegensburgCompleted
-
Turku University HospitalKarolinska Institutet; Kuopio University HospitalCompletedAdolescent Idiopathic ScoliosisSweden, Finland
-
Medical University of WarsawCentre of Postgraduate Medical EducationNot yet recruitingTotal Knee Replacement
-
Mert ÖzcanCompletedChondropathy | Knee Effusion | Knee Hemarthrosis
-
Universidade Estadual do Oeste do ParanáFederal University of São PauloCompletedVentral HerniaBrazil
-
Shifa International HospitalCompletedPain | Surgery | Acute Cholecystitis | Morbidity, Multiple | Drain Site ComplicationPakistan
-
Oslo University HospitalCompletedEarly Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma PatientsMelanoma | ComplicationNorway
-
Izmir Katip Celebi UniversityRecruiting